Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uterine Tubes01:16

Uterine Tubes

3.3K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
3.3K
Uterus and Cervix01:18

Uterus and Cervix

6.9K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
6.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time abnormal behaviour detection using energy-efficient YOLO-based framework.

Scientific reports·2025
Same author

Enhancing pancreatic cancer diagnostics: Ensemble-based model for automated urine biomarker classification.

Computers in biology and medicine·2025
Same author

Exploring Nonlinear Reaction-Diffusion in Enzyme Immobilized Systems: Integer and Fractional Order Modeling.

Applied biochemistry and biotechnology·2024
Same author

Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric study.

Epilepsy research·2024
Same author

A New Wavelet Collocation Algorithm for Solving a Nonlinear Boundary Value Problem of the Human Corneal Shape.

Nonlinear dynamics, psychology, and life sciences·2023

Related Experiment Video

Updated: Mar 20, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.8K

Uterine Sarcoma: The Indian Scenario.

S Sivakumari1, R Rajaraman2, S Subbiah2

  • 1Department of Surgical Oncology, GAAMCH, Kanchipuram, India.

Indian Journal of Surgical Oncology
|May 25, 2016
PubMed
Summary
This summary is machine-generated.

Uterine sarcomas are rare gynaecologic cancers. Disease stage at diagnosis is the key factor impacting survival, with most recurrences occurring within a year of initial detection.

Keywords:
CarcinosarcomaEndometrial stromal sarcomaGynaecologic cancersGynaecologic sarcomaLeiomyosarcomaUterine sarcoma

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Related Experiment Videos

Last Updated: Mar 20, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.8K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Area of Science:

  • Gynaecologic Oncology
  • Surgical Pathology
  • Clinical Outcomes Research

Background:

  • Uterine sarcomas are rare, highly malignant gynaecologic tumours, accounting for less than 1% of all such malignancies.
  • Understanding their clinical presentation, histopathology, and outcomes is crucial for improving patient management.

Purpose of the Study:

  • To evaluate the clinical presentation, histopathologic patterns, and treatment outcomes of uterine sarcomas.
  • To identify prognostic factors influencing survival in uterine sarcoma patients.

Main Methods:

  • Retrospective analysis of all histologically confirmed uterine sarcoma cases over an 8-year period (2004-2012) at a tertiary referral centre.
  • Data collected included clinical presentation, histopathology, treatment modalities, and patient outcomes.
  • Follow-up data was analyzed to determine recurrence rates and survival.

Main Results:

  • The predominant histopathologies were endometrial stromal sarcoma (n=13) and carcinosarcoma (n=8).
  • Most patients presented with Stage I disease (14/21).
  • Disease recurrence was observed in 47% of patients, with local recurrence (30%) and pulmonary metastases (17%) being common; all deaths occurred within one year of recurrence.

Conclusions:

  • Disease stage at diagnosis is the sole prognostic factor correlating with survival in uterine sarcomas.
  • Adjuvant treatment was not administered to the majority of patients with disease confined to the uterus.
  • Early diagnosis and appropriate staging are critical for improving outcomes in uterine sarcoma patients.